# Task B15: Drug synthesis for pre-clinical in vivo and exploratory toxicology studies

> **NIH NIH N01** · SRI INTERNATIONAL · 2021 · $52,102

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 10329706
- **Project number:** 272201800001I-P00002-759302000004-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** JOHN MIRSALIS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $52,102
- **Award type:** —
- **Project period:** 2020-05-18 → 2021-01-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10329706

## Citation

> US National Institutes of Health, RePORTER application 10329706, Task B15: Drug synthesis for pre-clinical in vivo and exploratory toxicology studies (272201800001I-P00002-759302000004-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10329706. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*